[Special Stock] Alzheimer Early Diagnosis Related Stocks... PeopleBio Hits Upper Limit↑
PeopleBio, a company possessing technology related to the early diagnosis of Alzheimer's disease, has hit the upper price limit.
As of 2:05 PM on the 29th, PeopleBio is trading on the KOSDAQ market at 3,750 KRW, up 865 KRW (29.98%) from the previous day.
Founded in September 2002, PeopleBio is a company primarily engaged in pharmaceutical development using biotechnology, food ingredient development, chemical substance development and supply, and consulting.
The company's main product includes a blood test product that can be used for the early diagnosis of Alzheimer's disease, one of the representative degenerative brain diseases.
Hot Picks Today
"Once Worth 4 Million Won a Day, Now Going for Chicken Money"... Chinese Robots' Humiliating Fall to 'Bargain-Bin' Prices in Just One Year
- "I Won't Take It Even If You Leave It to Me"... 9 Million Parents' Homes Sit Empty as 320,000 Japanese Renounce Inheritances
- One Facial Photo, and You're Told '90 Days to Live'... A Modern-Day Grim Reaper?
- Daughter in Her 30s Ate Tteokbokki Alone... 34-kg Father Dies of Malnutrition
- Serial Arson at Two Buildings in Yeoksam-dong; Police Arrest Suspect (3rd Update)
Currently, the Alzheimer's blood test under the AlzOn brand is being conducted at 120 medical institutions nationwide, including advanced general hospitals, health screening centers, and clinics.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
